title: Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications.
authors.forename: J R
authors.initials: JR
authors.lastname: Vane
authors.forename: T W
authors.initials: TW
authors.lastname: Meade
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D016861:Cyclooxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin